JORDAN ERICA (Chief Commercial Officer) reported 2 transactions at REVANCE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/6/2025ACC: 0000950170-25-015356
Officer· Chief Commercial Officer
Since Feb 2024
-114.86K
Net shares
Net seller
$25.3K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
114.86K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−6.92K
Price / share
$3.65
Trade value
$25.27K
% of position
6.0%
2/4/2025
114.86K→107.94K
Common Stock
Direct
Shares
−107.94K
Price / share
—
Trade value
—
% of position
New position
2/6/2025
107.94K→0.00
Total
Net shares
−114.86K
Net value
-$25.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | U · U | −6.92K | $3.65 | $25.27K | 6.0% | 114.86K | 107.94K |
| Common Stock Direct | 2/6/2025 | D · Disposition | −107.94K | — | — | New position | 107.94K | 0.00 |
| Total | −114.86K | -$25.27K | ||||||
Derivative Transactions0
No derivative transactions reported